ATA918577A - Verfahren zur herstellung von neuen, alfa- -glucosidasen inhibierenden aminozucker- derivaten - Google Patents

Verfahren zur herstellung von neuen, alfa- -glucosidasen inhibierenden aminozucker- derivaten

Info

Publication number
ATA918577A
ATA918577A AT918577A AT918577A ATA918577A AT A918577 A ATA918577 A AT A918577A AT 918577 A AT918577 A AT 918577A AT 918577 A AT918577 A AT 918577A AT A918577 A ATA918577 A AT A918577A
Authority
AT
Austria
Prior art keywords
glucosidases
alfa
new
production
derivatives inhibiting
Prior art date
Application number
AT918577A
Other languages
English (en)
Other versions
AT357568B (de
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762658562 external-priority patent/DE2658562A1/de
Priority claimed from DE19772726207 external-priority patent/DE2726207A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Priority to AT338979A priority Critical patent/AT357569B/de
Publication of ATA918577A publication Critical patent/ATA918577A/de
Application granted granted Critical
Publication of AT357568B publication Critical patent/AT357568B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT918577A 1976-12-23 1977-12-21 Verfahren zur herstellung von neuen, alfa- -glucosidasen inhibierenden aminozucker- derivaten AT357568B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT338979A AT357569B (de) 1976-12-23 1979-05-07 Verfahren zur herstellung von neuen amino- zuckerderivaten

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762658562 DE2658562A1 (de) 1976-12-23 1976-12-23 Aminozuckerderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE19772726207 DE2726207A1 (de) 1977-06-10 1977-06-10 Aminozuckerderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ATA918577A true ATA918577A (de) 1979-12-15
AT357568B AT357568B (de) 1980-07-25

Family

ID=25771297

Family Applications (1)

Application Number Title Priority Date Filing Date
AT918577A AT357568B (de) 1976-12-23 1977-12-21 Verfahren zur herstellung von neuen, alfa- -glucosidasen inhibierenden aminozucker- derivaten

Country Status (11)

Country Link
US (1) US4175123A (de)
JP (1) JPS5938959B2 (de)
AT (1) AT357568B (de)
CA (1) CA1096375A (de)
CH (1) CH641813A5 (de)
ES (1) ES465340A1 (de)
FR (1) FR2375248A1 (de)
GB (1) GB1556345A (de)
HK (1) HK23782A (de)
NL (1) NL7714142A (de)
SE (1) SE449104B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5953920B2 (ja) * 1977-12-28 1984-12-27 東洋醸造株式会社 新規なアミノ糖化合物およびその製法
JPS5643294A (en) * 1979-09-19 1981-04-21 Meiji Seika Kaisha Ltd Novel antibiotic sf-1130x substance, its preparation, and use
GB2064527B (en) * 1979-12-08 1984-05-02 Nippon Shinyaku Co Ltd Moranoline derivatives and process for preparation thereof
FR2492830A1 (fr) * 1980-10-29 1982-04-30 Sori Soc Rech Ind Nouveaux composes appartenant a la famille des benzoyl- et a-hydroxybenzyl-phenyl-osides, leur procede de preparation et leur application en therapeutique
US4526784A (en) * 1981-05-05 1985-07-02 Bayer Aktiengesellschaft Amino-cyclitol derivatives and medicaments containing them
DE3117705A1 (de) * 1981-05-05 1982-12-02 Bayer Ag, 5090 Leverkusen Aminocyclitderivate, ihre herstellung und sie enthaltende arnzeimittel
DE3123520A1 (de) * 1981-06-13 1982-12-30 Bayer Ag, 5090 Leverkusen Gesaettigte aminocyclitderivate, ihre herstellung undsie enthaltende arzneimittel
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
JPS6185254U (de) * 1984-11-08 1986-06-04
US5324828A (en) * 1986-12-11 1994-06-28 Genzyme Corporation 1-amino-1-deoxyoligosaccharides and derivatives thereof
ATE171953T1 (de) * 1986-12-11 1998-10-15 Genzyme Corp Ein verfahren zur herstellung eines 1-amino-1- deoxyoligosaccharid-derivats
US6297363B1 (en) * 1993-02-12 2001-10-02 Nomura Co., Ltd. Glycoside indoles
EP1745790A3 (de) * 2000-05-24 2007-03-21 Pfizer Limited Behandlung von Pansenacidose mit Amylasehemmern
US7022684B2 (en) * 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
US9333247B2 (en) * 2007-07-03 2016-05-10 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
US8999954B2 (en) * 2007-07-03 2015-04-07 Childern's Hospital & Research Center at Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
JP5523313B2 (ja) 2007-07-03 2014-06-18 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド ポリシアル酸誘導体、製造方法、ならびにがん抗原産生の増強およびターゲティングにおける使用
EP2145538A1 (de) 2008-07-15 2010-01-20 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Pflanzen- und Materialschutzmittel

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3480613A (en) * 1967-07-03 1969-11-25 Merck & Co Inc 2-c or 3-c-alkylribofuranosyl - 1-substituted compounds and the nucleosides thereof
US4076930A (en) * 1968-12-13 1978-02-28 James Ellingboe Polysaccharide polyols
AR204612A1 (es) * 1972-05-30 1976-02-20 Ciba Geigy Ag Procedimiento para obtener nuevos derivados de anhidrofuranosa
US4016261A (en) * 1973-03-01 1977-04-05 Strategic Medical Research Corporation Therapeutic composition and method of therapeutically treating warm blooded animals therewith
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
DE2347782C3 (de) * 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
DE2413720C3 (de) * 1974-03-21 1980-03-27 Bayer Ag, 5090 Leverkusen Tierfutter
DE2614393C3 (de) * 1976-04-02 1980-04-03 Bayer Ag, 5090 Leverkusen Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
JPS5379841A (en) 1978-07-14
GB1556345A (en) 1979-11-21
ES465340A1 (es) 1978-09-16
HK23782A (en) 1982-06-11
NL7714142A (nl) 1978-06-27
US4175123A (en) 1979-11-20
SE449104B (sv) 1987-04-06
JPS5938959B2 (ja) 1984-09-20
CH641813A5 (de) 1984-03-15
FR2375248B1 (de) 1982-07-30
SE7714660L (sv) 1978-06-24
FR2375248A1 (fr) 1978-07-21
CA1096375A (en) 1981-02-24
AT357568B (de) 1980-07-25

Similar Documents

Publication Publication Date Title
AT351164B (de) Verfahren zur herstellung von neuen cephalos- porinderivaten
ATA348877A (de) Verfahren zur herstellung von neuen n- acylierten
ATA918577A (de) Verfahren zur herstellung von neuen, alfa- -glucosidasen inhibierenden aminozucker- derivaten
AT349634B (de) Verfahren zur herstellung von neuen anthra- cyclinglycosiden
AT348535B (de) Verfahren zur herstellung von neuen 1,2- dithiolderivaten
AT349028B (de) Verfahren zur herstellung von neuen 1,2- dithiolderivaten
AT350722B (de) Verfahren zur herstellung von neuen kanamycin- derivaten
AT352875B (de) Verfahren zur herstellung von neuen 4-oxa-1- azabicyclo-(3,2,0)heptan-7-onderivaten
AT352279B (de) Verfahren zur herstellung von neuen rifamyzin- verbindungen
ATA303477A (de) Verfahren zur herstellung von neuen indazolyl- (4-)-oxy-propanolaminen
AT347457B (de) Verfahren zur herstellung von neuen indolinospiropyranverbindungen
ATA145077A (de) Verfahren zur herstellung von neuen ergolen- -derivaten
AT358577B (de) Verfahren zur herstellung von neuen 1-acyl-4- -hydroxy-imidazol-5-carboxamid-derivaten
ATA664176A (de) Verfahren zur herstellung von neuen n-alkyl -2,4-dinitro-6- trifluormethyldiphenylaminen
AT352280B (de) Verfahren zur herstellung von neuen rifamyzin- verbindungen
AT353411B (de) Verfahren zur herstellung von neuen 4- -dedimethylamino-4-arylsulfonamido-5a,6- -anhydrotetracyclinen
AT339922B (de) Verfahren zur kontinuierlichen herstellung von 2,5-dioxo -1-oxa-2- phospholanen
AT347939B (de) Verfahren zur herstellung von neuen, substi- tuierten 1,2,4-oxadiazolidin-3-on-verbindungen
AT351558B (de) Verfahren zur herstellung von neuen 2-formyl- amino-phenylguanidinen
ATA893377A (de) Verfahren zur herstellung von neuen thieno- thiazinderivaten
AT346354B (de) Verfahren zur herstellung von neuen 2- morpholinonderivaten
AT352116B (de) Verfahren zur herstellung von neuen 1,4- diphenylpyrazolderivaten
ATA350077A (de) Verfahren zur herstellung von neuen derivaten des 1-hydroxybenzo-2-3,1-diazaborins
ATA153578A (de) Verfahren zur herstellung von neuen 1,2- dithiolderivaten
ATA328176A (de) Verfahren zur herstellung von neuen pteridin-5,8-dioxiden

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee